(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...

Technologycategory Salesforce shares jump on report that Starboard has taken a stake October 18, 2022 Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia ...

Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported late Sunday. Citing unnamed ...

Starboard Value has its next target: the pharma giant Pfizer. The activist investor has informed Pfizer that it has taken a significant stake in the drugmaker, people familiar with the matter told ...

NEW YORK--(BUSINESS WIRE)--Starboard Value LP (together with its affiliates, “Starboard” or “we”), a significant shareholder of Pfizer Inc. (NYSE: PFE ...

Corvex invested in Durham, North Carolina-based Fortrea after another activist investor, Starboard Value LP, disclosed its ...

NEW YORK, Oct 22 (Reuters) - Activist hedge fund Starboard Value's chief executive officer said on Tuesday that drugmaker Pfizer's (PFE.N), opens new tab board needs to hold management accountable ...

Pfizer's stock (PFE) surged more than 4% Monday morning after reports that activist investor Starboard Value had taken a $1 billion stake in the pharma giant. The investor wants to help turn ...

Activist investor Starboard Value has taken a ~$1 billion stake in Pfizer (NYSE:PFE) and is pushing the company to make changes. More details of Starboard's plans and interactions with Pfizer (PFE ...

Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Activist investor Starboard Value, which in recent months has taken stakes in coffee chain Starbucks (SBUX) and pharmaceutical giant Pfizer (PFE), has set its sights on Kenvue (KVUE). The Wall ...

Starboard Chief Executive Jeff Smith, whose fund has a roughly $1 billion stake in Pfizer, said Tuesday that the pharmaceutical company's board should be laser-focused on tracking its return on R ...